Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination
- PMID: 11494411
- DOI: 10.1002/glia.1085
Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination
Abstract
An association between macrophages and remyelination efficiency has been observed in a variety of different models of CNS demyelination. In order to test whether this association is causal or coincidental, we have examined the effects of macrophage depletion on the rate of remyelination of lysolecithin-induced demyelination in the spinal cord of young adult female rats. Macrophage depletion was achieved by reducing the monocyte contribution to the macrophages within the lesion using the clodronate-liposome technique. This technique not only resulted in a decrease in Ox-42-positive cells in the spleen of treated animals but also in the levels of macrophage scavenger receptor type B mRNA expression within the demyelinating lesion. In animals treated with clodronate-liposomes throughout the remyelination process, there was a significant decrease in the extent of oligodendrocyte remyelination at 3 weeks after lesion induction, but no effect on Schwann cell remyelination. If macrophage depletion was delayed until the second half of the remyelination phase, then there was no effect on the repair outcome, implying that macrophages are required for the early stages of CNS remyelination. The results of this study indicate that the macrophage response is an important component of successful CNS remyelination and that approaches to the treatment of demyelinating disease based on inhibition of the inflammatory response may also impair regenerative events that follow demyelination.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
-
Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression.Neurobiol Dis. 2005 Feb;18(1):166-75. doi: 10.1016/j.nbd.2004.09.019. Neurobiol Dis. 2005. PMID: 15649707
-
Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice.Glia. 2002 Mar 1;37(3):241-9. doi: 10.1002/glia.10033. Glia. 2002. PMID: 11857682
-
E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord.Glia. 2017 Jun;65(6):883-899. doi: 10.1002/glia.23132. Epub 2017 Mar 2. Glia. 2017. PMID: 28251686 Free PMC article.
-
The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.Adv Exp Med Biol. 1999;468:183-97. doi: 10.1007/978-1-4615-4685-6_15. Adv Exp Med Biol. 1999. PMID: 10635029 Review.
-
Oligodendrocyte-protection and remyelination post-spinal cord injuries: a review.Prog Neurobiol. 2012 Mar;96(3):322-39. doi: 10.1016/j.pneurobio.2012.01.008. Epub 2012 Jan 28. Prog Neurobiol. 2012. PMID: 22307058 Review.
Cited by
-
Glial Cells as Key Regulators in Neuroinflammatory Mechanisms Associated with Multiple Sclerosis.Int J Mol Sci. 2024 Sep 4;25(17):9588. doi: 10.3390/ijms25179588. Int J Mol Sci. 2024. PMID: 39273535 Free PMC article. Review.
-
The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation.J Neurosci. 2002 Apr 1;22(7):2451-9. doi: 10.1523/JNEUROSCI.22-07-02451.2002. J Neurosci. 2002. PMID: 11923409 Free PMC article.
-
Promoting remyelination in multiple sclerosis-recent advances.Drugs. 2013 Dec;73(18):2017-29. doi: 10.1007/s40265-013-0146-8. Drugs. 2013. PMID: 24242317 Free PMC article. Review.
-
Partial Depletion of Peripheral M1 Macrophages Reverses Motor Deficits in MPTP-Treated Mouse by Suppressing Neuroinflammation and Dopaminergic Neurodegeneration.Front Aging Neurosci. 2018 Jun 5;10:160. doi: 10.3389/fnagi.2018.00160. eCollection 2018. Front Aging Neurosci. 2018. PMID: 29922149 Free PMC article.
-
Inefficient clearance of myelin debris by microglia impairs remyelinating processes.J Exp Med. 2015 Apr 6;212(4):481-95. doi: 10.1084/jem.20141656. Epub 2015 Mar 16. J Exp Med. 2015. PMID: 25779633 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical